CRISPR Therapeutics has figured out a way to successfully repair genetic code. Monetizing this know-how is the next step.
Source: https://www.fool.com/investing/2025/12/23/3-brilliant-growth…
Nvidia remains well positioned to benefit from the AI infrastructure buildout. Broadcom has a huge opportunity in front of it with custom AI chips.
A last-ditch effort by GOP moderates to renew the subsidies may be on life support.
Broadcom has a massive opportunity ahead with custom AI chips. UiPath has huge potential upside as its revenue starts to accelerate.
